{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:45:30Z","timestamp":1789008330333,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T00:00:00Z","timestamp":1278979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12072-010-9186-2","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T12:25:33Z","timestamp":1278937533000},"page":"569-576","source":"Crossref","is-referenced-by-count":25,"title":["Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population"],"prefix":"10.1007","volume":"4","author":[{"given":"Balkrishan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh Kumar","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupesh","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Chakraborthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha Krishan","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,13]]},"reference":[{"key":"9186_CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153\u2013156","journal-title":"Int J Cancer"},{"key":"9186_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","volume":"340","author":"HB El-Serag","year":"1999","unstructured":"El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745\u2013750","journal-title":"N Engl J Med"},{"key":"9186_CR3","first-page":"13","volume-title":"Liver Cancer","author":"FX Bosch","year":"1997","unstructured":"Bosch FX. Global epidemiology of hepatocellular carcinoma. In Okuda K, Tabor E, editors. Liver Cancer. New York: Churchill Livingstone; 1997. p 13\u201327"},{"key":"9186_CR4","first-page":"1990","volume-title":"National Cancer Registry Programme","author":"Annual Report","year":"1987","unstructured":"Report Annual. National Cancer Registry Programme. New Delhi: Indian Council of Medical Research; 1987. p 1990"},{"key":"9186_CR5","unstructured":"Jayant K, Rao RS, Nene BM, Dale PS. Rural Cancer Registry at Barshi\u2014Report 1988\u20131992. Barshi: Rural Cancer Registry;1994"},{"key":"9186_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00000658-200107000-00010","volume":"234","author":"RT Poon","year":"2001","unstructured":"Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10\u00a0years. Ann Surg 2001;234:63\u201370","journal-title":"Ann Surg"},{"key":"9186_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/lt.20175","volume":"10","author":"RT Poon","year":"2004","unstructured":"Poon RT, Fan ST. Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl 2004;10:813\u2013815","journal-title":"Liver Transpl"},{"key":"9186_CR8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00000658-200204000-00004","volume":"235","author":"RT Poon","year":"2002","unstructured":"Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon\u2019s perspective. Ann Surg 2002;235:466\u2013486","journal-title":"Ann Surg"},{"key":"9186_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0016-5085(86)90919-4","volume":"90","author":"YF Liaw","year":"1986","unstructured":"Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, Pao CC. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 1986;90:263\u2013267","journal-title":"Gastroenterology"},{"key":"9186_CR10","first-page":"417","volume":"130","author":"BH Zhang","year":"2004","unstructured":"Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417\u2013422","journal-title":"J Cancer Res Clin Oncol"},{"key":"9186_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0016-5085(84)80020-7","volume":"86","author":"T Shinagawa","year":"1984","unstructured":"Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, Tsuchiya Y, Saotome N, Karasawa E, Miki M, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984;86:495\u2013502","journal-title":"Gastroenterology"},{"key":"9186_CR12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.1840170610","volume":"17","author":"K Ikeda","year":"1993","unstructured":"Ikeda K, Saitoh S, Koida I, Tsubota A, Arase Y, Chayama K, Kumada H. Diagnosis and follow-up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography. Hepatology 1993;17:1003\u20131007","journal-title":"Hepatology"},{"key":"9186_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep.1840190111","volume":"19","author":"H Oka","year":"1994","unstructured":"Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61\u201366","journal-title":"Hepatology"},{"key":"9186_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2214\/ajr.155.1.1693808","volume":"155","author":"K Takayasu","year":"1990","unstructured":"Takayasu K, Moriyama N, Muramatsu Y, Makuuchi M, Hasegawa H, Okazaki N, Hirohashi S. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 1990;155:49\u201354","journal-title":"Am J Roentgenol"},{"key":"9186_CR15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2214\/ajr.164.4.7726041","volume":"164","author":"K Takayasu","year":"1995","unstructured":"Takayasu K, Furukawa H, Wakao F, Muramatsu Y, Abe H, Terauchi T, Winter TC III, Sakamoto M, Hirohashi S. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. Am J Roentgenol 1995;164:885\u2013890","journal-title":"Am J Roentgenol"},{"key":"9186_CR16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiology.159.2.3008213","volume":"159","author":"M Ebara","year":"1986","unstructured":"Ebara M, Ohto M, Watanabe Y, Kimura K, Saisho H, Tsuchiya Y, Okuda K, Arimizu N, Kondo F, Ikehira H, et al. Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies. Radiology 1986;159:371\u2013377","journal-title":"Radiology"},{"key":"9186_CR17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1572-0241.2004.04152.x","volume":"99","author":"KQ Hu","year":"2004","unstructured":"Hu KQ, Kyulo NL, Lim N, Elhazin B, Hillebrand DJ, Bock T. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 2004;99:860\u2013865","journal-title":"Am J Gastroenterol"},{"key":"9186_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MCG.0b013e318182015a","volume":"43","author":"HS Kim","year":"2009","unstructured":"Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. J Clin Gastroenterol 2009;43:482\u2013488","journal-title":"J Clin Gastroenterol"},{"key":"9186_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cgh.2008.08.041","volume":"7","author":"RK Sterling","year":"2009","unstructured":"Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol 2009;7:104\u2013113","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9186_CR20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2407-8-200","volume":"8","author":"G Beale","year":"2008","unstructured":"Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, Trerotoli P, Giannelli G, Manas D, Reeves H. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer 2008;8:200","journal-title":"BMC Cancer"},{"key":"9186_CR21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1440-1746.2008.05395.x","volume":"23","author":"FA Durazo","year":"2008","unstructured":"Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2008;23:1541\u20131548","journal-title":"J Gastroenterol Hepatol"},{"key":"9186_CR22","first-page":"66","volume":"92","author":"P Gentilini","year":"1997","unstructured":"Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli G, Casini-Raggi V, Melani L, Mazzanti R, Riccardi D, Pinzani M, Zignego AL. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 1997;92:66\u201372","journal-title":"Am J Gastroenterol"},{"key":"9186_CR23","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/gast.2001.24839","volume":"120","author":"AS Lok","year":"2001","unstructured":"Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000\u2014summary of a workshop. Gastroenterology. 2001;120:1828\u20131853","journal-title":"Gastroenterology"},{"key":"9186_CR24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.1840060432","volume":"6","author":"K Okuda","year":"1986","unstructured":"Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986;6:729\u2013738","journal-title":"Hepatology"},{"key":"9186_CR25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<977::AID-CNCR6>3.0.CO;2-9","volume":"78","author":"M Zoli","year":"1996","unstructured":"Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977\u2013985","journal-title":"Cancer"},{"key":"9186_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2005-871194","volume":"25","author":"M Sherman","year":"2005","unstructured":"Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005;25:143\u2013154","journal-title":"Semin Liver Dis"},{"key":"9186_CR27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJM198405313102204","volume":"310","author":"HA Liebman","year":"1984","unstructured":"Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427\u20131431","journal-title":"N Engl J Med"},{"key":"9186_CR28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840110321","volume":"11","author":"SL Tsai","year":"1990","unstructured":"Tsai SL, Huang GT, Yang PM, Sheu JC, Sung JL, Chen DS. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology 1990;11:481\u2013488","journal-title":"Hepatology"},{"key":"9186_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/lt.500010410","volume":"1","author":"GL Grazi","year":"1995","unstructured":"Grazi GL, Mazziotti A, Legnani C, Jovine E, Miniero R, Gallucci A, Palareti G, Gozzetti G. The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin. Liver Transpl Surg 1995;1:249\u2013255","journal-title":"Liver Transpl Surg"},{"key":"9186_CR30","first-page":"1036","volume":"95","author":"M Ishii","year":"2000","unstructured":"Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Am J Gastroenterol 2000;95:1036\u20131040","journal-title":"Am J Gastroenterol"},{"key":"9186_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-2007-3202","volume":"3","author":"ML Volk","year":"2007","unstructured":"Volk ML, Hernandez JC, Su GL, Lok AS, Marrero JA. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark 2007;3:79\u201387","journal-title":"Cancer Biomark"},{"key":"9186_CR32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/jhep.2003.50195","volume":"37","author":"JA Marrero","year":"2003","unstructured":"Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 2003;37:1114\u20131121","journal-title":"Hepatology"},{"key":"9186_CR33","first-page":"2489","volume":"19","author":"R Lamerz","year":"1999","unstructured":"Lamerz R, Runge M, Stieber P, Meissner E. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases. Anticancer Res 1999;19:2489\u20132493","journal-title":"Anticancer Res"},{"key":"9186_CR34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-2143(96)90146-8","volume":"127","author":"BM Grosley","year":"1996","unstructured":"Grosley BM, Hirschauer C, Chambrette B, Bezeaud A, Amiral J. Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma. J Lab Clin Med 1996;127:553\u2013564","journal-title":"J Lab Clin Med"},{"key":"9186_CR35","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/BF01299891","volume":"38","author":"A Kasahara","year":"1993","unstructured":"Kasahara A, Hayashi N, Fusamoto H, Kawada Y, Imai Y, Yamamoto H, Hayashi E, Ogihara T, Kamada T. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Dig Dis Sci 1993;38:2170\u20132176","journal-title":"Dig Dis Sci"},{"key":"9186_CR36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<544::AID-CNCR8>3.0.CO;2-F","volume":"88","author":"H Okuda","year":"2000","unstructured":"Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma. Cancer 2000;88:544\u2013549","journal-title":"Cancer"},{"key":"9186_CR37","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/1097-0142(19810601)47:11<2746::AID-CNCR2820471134>3.0.CO;2-K","volume":"47","author":"CL Lai","year":"1981","unstructured":"Lai CL, Lam KC, Wong KP, Wu PC, Todd D. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981;47:2746\u20132755","journal-title":"Cancer"},{"key":"9186_CR38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0142(197707)40:1<319::AID-CNCR2820400145>3.0.CO;2-Q","volume":"40","author":"Y Shimokawa","year":"1977","unstructured":"Shimokawa Y, Okuda K, Kubo Y, Kaneko A, Arishima T, Nagata E, Hashimoto M, Sawa Y, Nagasaki Y, Kojiro M, Sakamoto K, Nakashima T. Serum glutamic oxalacetic transaminase\/glutamic pyruvic transaminase ratios in hepatocellular carcinoma. Cancer 1977;40:319\u2013324","journal-title":"Cancer"},{"key":"9186_CR39","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/j.1572-0241.2006.00681.x","volume":"101","author":"S Nakamura","year":"2006","unstructured":"Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Am J Gastroenterol 2006;101:2038\u20132043","journal-title":"Am J Gastroenterol"},{"key":"9186_CR40","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1097-0142(19940515)73:10<2464::AID-CNCR2820731004>3.0.CO;2-9","volume":"73","author":"T Suehiro","year":"1994","unstructured":"Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer 1994;73:2464\u20132471","journal-title":"Cancer"},{"key":"9186_CR41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jjco\/hyg096","volume":"33","author":"M Gotoh","year":"2003","unstructured":"Gotoh M, Nakatani T, Masuda T, Mizuguchi Y, Sakamoto M, Tsuchiya R, Kato H, Furuta K. Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin. Jpn J Clin Oncol 2003;33:522\u2013526","journal-title":"Jpn J Clin Oncol"},{"key":"9186_CR42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","volume":"91","author":"Y Koike","year":"2001","unstructured":"Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Yoshida H, Shiina S, Omata M. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001;91:561\u2013569","journal-title":"Cancer"},{"key":"9186_CR43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.510270140","volume":"27","author":"J Collier","year":"1998","unstructured":"Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273\u2013278","journal-title":"Hepatology"},{"issue":"suppl 6","key":"9186_CR44","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1097\/00000374-200106001-00011","volume":"25","author":"M Ohhira","year":"2001","unstructured":"Ohhira M, Saito H, Suzuki Y, Naraki T, Sakurai S, Ohtake T, Suzuki M, Ohhira M, Fujimoto And Y, Kohgo Y. A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma. Alcohol Clin Exp Res 2001;25(suppl 6):46S\u201350S","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-010-9186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-010-9186-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-010-9186-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T07:09:32Z","timestamp":1711609772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-010-9186-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,13]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9186"],"URL":"https:\/\/doi.org\/10.1007\/s12072-010-9186-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,13]]}}}